Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
ClinicalTrials.gov study NCT03720470. IPD Sharing: YES. Countries: 18. Publications: 10.
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
ClinicalTrials.gov study NCT01407094. IPD Sharing: YES. Countries: 1. Publications: 21.
Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01313221. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty
ClinicalTrials.gov study NCT02820324. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)
ClinicalTrials.gov study NCT00608777. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab
ClinicalTrials.gov study NCT02937701. IPD Sharing: Not stated. Countries: 9. Publications: 1.
A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis
ClinicalTrials.gov study NCT00336492. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms
ClinicalTrials.gov study NCT04430855. IPD Sharing: YES. Countries: 4. Publications: 0.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
ClinicalTrials.gov study NCT01621178. IPD Sharing: YES. Countries: 9. Publications: 2.
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
ClinicalTrials.gov study NCT02827708. IPD Sharing: YES. Countries: 8. Publications: 7.
Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00428090. IPD Sharing: YES. Countries: 20. Publications: 1.
Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT00678470. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE)
ClinicalTrials.gov study NCT05114434. IPD Sharing: YES. Countries: 1. Publications: 14.
A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis
ClinicalTrials.gov study NCT05223868. IPD Sharing: YES. Countries: 10. Publications: 2.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT00783718. IPD Sharing: Not stated. Countries: 3. Publications: 14.
A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2
ClinicalTrials.gov study NCT04003142. IPD Sharing: YES. Countries: 7. Publications: 6.
A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis
ClinicalTrials.gov study NCT05656911. IPD Sharing: NO. Countries: 7. Publications: 1.
Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma
ClinicalTrials.gov study NCT01340209. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD
ClinicalTrials.gov study NCT02766608. IPD Sharing: Not stated. Countries: 8. Publications: 2.
A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)
ClinicalTrials.gov study NCT04996797. IPD Sharing: YES. Countries: 12. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.